Apg Asset Management N.V. Legend Biotech Corp Transaction History

Apg Asset Management N.V.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$38.15 - $57.1 $15,260 - $22,840	-400 Reduced 6.67%	5,600 $233,000
Q2 2022 Aug 12, 2022	SELL	$33.54 - $55.0 $160,992 - $264,000	-4,800 Reduced 44.44%	6,000 $316,000
Q1 2022 May 12, 2022	BUY	$31.02 - $48.18 $335,016 - $520,344	10,800 New	10,800 $353,000

212

77.9M

412K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.73B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

Stay updated on Apg Asset Management N.V. with notifications on news.